Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily F Mason

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Pathology|June 3, 2017
Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative DisordersEmily F Mason, Olga Pozdnyakova, Betty Li, et al.
Blood Advances|November 13, 2024
Diagnosis of TP53-mutated myeloid disease by the ICC and WHO fifth edition classificationsStephanie A Hart, Laura A Lee, Adam C Seegmiller, et al.
Blood Advances|November 8, 2019
Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcomeEmily F Mason, Robert P Hasserjian, Nidhi Aggarwal, et al.
Blood Vessels, Thrombosis & Hemostasis|January 2, 2026
Limited availability of variant-specific germ line data creates challenges in the interpretation of myeloid NGS panelsAaron Jacob Winer, Emily F Mason, Alexander G Bick, et al.
American Journal of Hematology|December 24, 2017
A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcomeEmily F Mason, Frank C Kuo, Robert P Hasserjian, et al.
Journal of Pediatric Hematology/Oncology|September 26, 2022
Thrombotic Microangiopathy Due to Progressive Disseminated Histoplasmosis in a Child With Down Syndrome and Acute Lymphoblastic LeukemiaBrittany A Cowfer, Tracy E Hunley, Emily F Mason, et al.
Leukemia & Lymphoma|September 6, 2021
Chronic myeloid leukemia with pure erythroid leukemia blast crisisJeremy W Jacobs, Rahul Ramaswamy, Vanessa States, et al.
Cancer Research|September 30, 2010
Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-AblEmily F Mason, Yuxing Zhao, Pankuri Goraksha-Hicks, et al.
Clinical Case Reports|February 17, 2025
Multisite Head and Neck Pediatric Posttransplant Lymphoproliferative Disorder: A Case ReportLily Gao, Austin Hoke, Jarrett Jackson, et al.
The American Journal of Surgical Pathology|June 26, 2013
Identification of succinate dehydrogenase-deficient bladder paragangliomasEmily F Mason, Peter M Sadow, Andrew J Wagner, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Pathology|June 3, 2017
Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative DisordersEmily F Mason, Olga Pozdnyakova, Betty Li, et al.
Blood Advances|November 13, 2024
Diagnosis of TP53-mutated myeloid disease by the ICC and WHO fifth edition classificationsStephanie A Hart, Laura A Lee, Adam C Seegmiller, et al.
Blood Advances|November 8, 2019
Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcomeEmily F Mason, Robert P Hasserjian, Nidhi Aggarwal, et al.
Blood Vessels, Thrombosis & Hemostasis|January 2, 2026
Limited availability of variant-specific germ line data creates challenges in the interpretation of myeloid NGS panelsAaron Jacob Winer, Emily F Mason, Alexander G Bick, et al.
American Journal of Hematology|December 24, 2017
A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcomeEmily F Mason, Frank C Kuo, Robert P Hasserjian, et al.
Journal of Pediatric Hematology/Oncology|September 26, 2022
Thrombotic Microangiopathy Due to Progressive Disseminated Histoplasmosis in a Child With Down Syndrome and Acute Lymphoblastic LeukemiaBrittany A Cowfer, Tracy E Hunley, Emily F Mason, et al.
Leukemia & Lymphoma|September 6, 2021
Chronic myeloid leukemia with pure erythroid leukemia blast crisisJeremy W Jacobs, Rahul Ramaswamy, Vanessa States, et al.
Cancer Research|September 30, 2010
Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-AblEmily F Mason, Yuxing Zhao, Pankuri Goraksha-Hicks, et al.
Clinical Case Reports|February 17, 2025
Multisite Head and Neck Pediatric Posttransplant Lymphoproliferative Disorder: A Case ReportLily Gao, Austin Hoke, Jarrett Jackson, et al.
The American Journal of Surgical Pathology|June 26, 2013
Identification of succinate dehydrogenase-deficient bladder paragangliomasEmily F Mason, Peter M Sadow, Andrew J Wagner, et al.
Pageof 4